STOCK TITAN

Auddia Inc. Warrants 8-K Filings

AUUDW NASDAQ

Every 8-K that Auddia Inc. Warrants (AUUDW) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow AUUDW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AUUDW filings page.

Rhea-AI Summary

Auddia Inc. filed an 8-K providing detailed financial information for its planned business combination with Thramann Holdings. The filing includes unaudited combined and consolidated financials for Thramann, which is pre-revenue and recorded net losses of $245,509 in Q1 2026 and $105,721 in Q1 2025, raising going concern doubts.

Thramann’s assets were $2.8 million as of March 31, 2026, largely driven by $2.8 million of intangible assets tied to patents and software, funded by consideration payable of $1.8 million. The filing also presents unaudited pro forma combined financials showing the merger will be accounted for as a reverse recapitalization, with Thramann as the accounting acquirer.

Pro forma data illustrate a planned $12.0 million equity financing for Auddia and issuance of $3.5 million of Pubco notes to Thramann’s owner. Auddia shareholders are expected to own about 20% of the combined company at closing, with the remainder held primarily by Jeff Thramann, subject to net cash and other adjustments.

Rhea-AI Summary

Auddia Inc. approved significant cash bonuses for its top executives and reported results from a recent special shareholder meeting. The Compensation Committee granted a $350,000 bonus to Chief Executive Officer Jeffrey Thramann and a $150,000 bonus to Chief Financial Officer John Mahoney, citing in part the successful completion of the Company’s recent $12 million public offering. These bonuses will be paid in the next regular pay period.

At the Special Meeting of Stockholders, shareholders approved giving the board discretionary authority to implement a proposed reverse stock split, with 803,150 votes for, 610,518 against, and 20,574 abstentions. Shareholders also approved a proposal to adjourn the meeting if needed, with 830,688 votes for, 580,223 against, and 23,330 abstentions.

Rhea-AI Summary

Auddia Inc. entered an Exchange Agreement with accredited investors to swap 750 outstanding shares of its Series C convertible preferred stock, including accrued dividends, for 216,525 shares of common stock at an exchange price of $3.91 per share. This transaction eliminates all remaining Series C preferred stock, leaving none outstanding. The preferred stock originally came from a prior $1,000,000 financing in which Auddia issued 1,000 Series C preferred shares at $1,000 per share. The exchange was conducted as an unregistered securities transaction relying on exemptions under Section 3(a)(9) and Section 4(a)(2) of the Securities Act.

Rhea-AI Summary

Auddia Inc. has commenced a public offering of 1,405,006 shares of common stock, pre-funded warrants to purchase up to 3,679,737 shares, and accompanying common warrants to purchase up to 5,084,743 shares. The offering is priced at $2.36 per share and associated common warrant, with pre-funded warrants priced at $2.359 and exercisable at $0.001.

The company expects gross proceeds of approximately $12 million and net proceeds of about $10.9 million after fees, which it plans to use, along with existing cash, for working capital and general corporate purposes. The common warrants are immediately exercisable at $2.36 per share and will expire upon completion of a specified merger transaction or five years after initial exercise, whichever comes first. Both warrant types include ownership caps generally at 4.99% or, at the purchaser’s election, 9.99% of outstanding common stock.

Rhea-AI Summary

Auddia Inc. approved a reverse stock split of its common stock at a 1-for-7.7 ratio, effective as of 5:00 p.m. Eastern Time on March 31, 2026. Every 7.7 issued and outstanding shares were combined into one share, with no change to par value.

Any fractional share resulting from the split is rounded up to one whole share at the participant level with DTC, so no fractional shares are issued. Trading on Nasdaq began on a split-adjusted basis on April 1, 2026 under a new CUSIP number. Outstanding common shares decreased from approximately 3.9 million to approximately 500,000, while authorized common shares remain 100 million. The split proportionately adjusts convertible preferred stock, warrants, stock options and restricted stock units, including their related exercise prices.

Rhea-AI Summary

Auddia Inc. filed audited financials for Thramann Holdings and detailed unaudited pro forma results for their planned business combination. Thramann’s ventures in AI travel, healthcare bundles, and solar-powered AI infrastructure are all pre-revenue and generated operating losses of $485,885 in 2025 and $324,746 in 2024, leading auditors to raise substantial doubt about its ability to continue as a going concern.

The companies signed a definitive merger agreement under which existing Auddia shareholders are expected to own about 20% of the combined public holding company, while entities controlled by Jeff Thramann are expected to own about 80%. The combined entity’s pro forma 2025 net loss is shown at roughly $8.7 million, with no revenue in 2024 or 2025, and the merger is conditioned on Auddia having at least $12 million of net cash at closing, supported by a planned $10.5 million equity financing.

Rhea-AI Summary

Auddia Inc. has signed a definitive merger agreement with Thramann Holdings, LLC to combine into a new holding company called McCarthy Finney, whose stock is expected to trade on Nasdaq under the ticker MCFN. At closing, Auddia shareholders are expected to own about 20% of McCarthy Finney, with roughly 80% owned by Jeff Thramann.

The merger is conditioned on Auddia having at least $12 million of cash on hand at closing to fund key business milestones. Management’s base case discounted cash flow analysis estimates McCarthy Finney’s valuation at $250 million. McCarthy Finney will fully own Auddia along with three AI‑focused companies—LT350, Influence Healthcare, and Voyex—currently controlled by Thramann Holdings.

The boards of both companies unanimously approved the transaction, and Houlihan Capital provided a fairness opinion to Auddia’s special committee and board. Closing is targeted for the second quarter of 2026, subject to Auddia stockholder approval, effectiveness of a Form S‑4 registration statement, required financing, and the combined company maintaining its Nasdaq listing.

Rhea-AI Summary

Auddia Inc. plans a transformative related-party merger with Thramann Holdings, combining both businesses into a new holding company, McCarthy Finney, that is expected to trade on Nasdaq under the ticker “MCFN.” Auddia and Thramann will become wholly owned subsidiaries of McCarthy Finney.

At closing, former Thramann holders are expected to have an approximately 80% economic interest in McCarthy Finney, while existing Auddia stockholders will hold about 20%, subject to adjustments based on Auddia’s net cash. Auddia must have at least $12 million of net cash at closing for the deal to proceed.

Thramann holders will receive Holdco Special Preferred Stock and $3.5 million of unsecured Holdco Notes bearing 8.0% interest and exchangeable into Special Preferred. The Special Preferred carries a stated value of $1,000 per share, a minimum aggregate liquidation preference of $20.5 million, broad voting and board designation rights, and conversion features tied to the Nasdaq minimum price.

Auddia’s special committee of independent directors unanimously approved the merger as fair and obtained a fairness opinion from Houlihan Capital. Audited financials show Thramann’s portfolio companies are pre-revenue with recurring operating losses and a going concern warning, meaning they will rely on continued funding and future execution.

Rhea-AI Summary

Auddia Inc. extended its exclusivity period under a non-binding letter of intent for a proposed business combination with Thramann Holdings, LLC. The exclusivity now runs through February 16, 2026, allowing more time to finalize definitive transaction documents.

The contemplated deal would restructure Auddia into an AI native public holding company, with both Auddia’s and Thramann Holdings’ portfolio companies becoming subsidiaries trading under a new name and ticker. The latest extension is intended to let the special committee’s fairness opinion provider update its analysis, and the company expects the committee’s review process to be completed on or before February 16, 2026.

Rhea-AI Summary

Auddia Inc. reported that it has again extended its exclusivity period under a non-binding letter of intent for a proposed business combination with Thramann Holdings, LLC. The exclusivity period, originally agreed in July–August 2025 and extended several times, will now run through January 31, 2026, during which the parties aim to negotiate a definitive business combination agreement. The contemplated transaction would reorganize Auddia into a public holding company, with the portfolio companies of both Auddia and Thramann Holdings becoming subsidiaries and trading under a new name and ticker symbol. Auddia also states that the special committee of independent directors evaluating the proposed business combination expects to complete its review process on or before January 31, 2026.

Rhea-AI Summary

Auddia Inc. reports the planned resignation of Chief Technology Officer Peter Shoebridge, effective August 29, 2025, and provides an update on recent financing moves. His departure is stated not to involve any disagreement over the company’s operations, policies, financial reporting, or controls, and he will receive nine months of base salary and up to nine months of COBRA premiums under his employment agreement.

In July and early August 2025, Auddia issued 360,000 common shares under its equity line with White Lion Capital for cash proceeds of $1.9 million, followed later in August by 610,000 additional shares for $1.77 million. The company also exchanged 569 Series B preferred shares (including accrued dividends) for 132,724 common shares at $4.486 per share, and later exchanged another 966 Series B preferred shares for 387,850 common shares at $2.65 per share, leaving no Series B preferred shares outstanding. Total common shares outstanding are now approximately 2,145,533 as of August 25, 2025.

Rhea-AI Summary

Auddia Inc. entered into an At-the-Market Issuance Sales Agreement with Ascendiant Capital Markets to sell shares of its common stock from time to time with an aggregate offering price capacity of up to $10,000,000 under an ATM structure. The company filed a prospectus supplement with the SEC on August 22, 2025 that sets the immediate offering limit at $3,042,500, reflecting the cap based on General Instruction I.B.6 of Form S-3. The filing references legal opinion and consent from Carroll Legal LLC and includes an interactive data file embedded within the Inline XBRL document. The 8-K is signed by John E. Mahoney, Chief Financial Officer.

Rhea-AI Summary

Auddia Inc. (Nasdaq: AUUD) filed an 8-K on 5 Aug 2025 disclosing it has signed a non-binding letter of intent (LOI) to explore a business combination with Thramann Holdings, LLC. The document contains no financial terms, structure, valuation, timetable or financing details; it merely references the related press release filed as Exhibit 99.1. The potential deal remains subject to further negotiation, due diligence, and board/shareholder approvals, therefore may never progress to a definitive agreement. Management did not update guidance or provide pro-forma metrics.